Please login to the form below

Not currently logged in
Email:
Password:

Tobira Therapeutics

This page shows the latest Tobira Therapeutics news and features for those working in and with pharma, biotech and healthcare.

Allergan buys regenerative medicine firm LifeCell for $2.9bn

Allergan buys regenerative medicine firm LifeCell for $2.9bn

Allergan's other deals in 2016 have included a $1.7bn acquisition of Tobira Therapeutics - which gave it two drug candidates for non-alcoholic steatohepatitis (NASH) - a $639m takeover of dermatology

Latest news

  • Gilead chalks up trial success for new NASH drug Gilead chalks up trial success for new NASH drug

    Along with selonsertib, Gilead is also developing an FXR agonist called GS-9674 in phase I trials and acquired a wholly-owned subsidiary of Nimbus Therapeutics for $1.2bn earlier this ... Allergan has been building a pipeline of candidates through a

  • Allergan buys two NASH drug developers in one day Allergan buys two NASH drug developers in one day

    More than $1.7bn paid for Tobira Therapeutics and Akarna Therapeutics.  Allergan has gone on the acquisition trail once again, stumping up more than $1.7bn for non-alcoholic steatohepatitis (NASH) ... The headline deal is the $1.69bn offered for Tobira

  • A competitive edge

    TBR 652 is currently being developed by Tobira Therapeutics. A phase IIa proof-of-concept trial evaluated the antiviral activity, safety and pharmacokinetics of TBR 652 in treatment-experienced, CCR5-naïve ... Philippines. Dalfampridine . Ampyra

More from news
Approximately 3 fully matching, plus 1 partially matching documents found.

Latest Intelligence

  • Deal Watch September 2016 Deal Watch September 2016

    Hogging the headlines …. Featuring in two entries in the September Deal Watch table, Allergan was busy splashing the cash with a $1.7bn acquisition of Tobira Therapeutics, hotly followed by the ... 1, 710. Tobira Therapeutics / Allergan. Acquisition

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Havas Life Medicom

We’re a specialist-led, unified communications agency delivering connected healthcare communications, informed through fresh insights, smart thinking and inspired ideas. Our...

Latest intelligence

PANDAS/PANS Awareness: A parent’s story
To help raise awareness of these often underdiagnosed diseases, Jon Hallows, Joint MD at Porterhouse shares his own experience as a parent of a son recently diagnosed with PANDAS...
Iskra Reic
Leading AstraZeneca’s return to growth in Europe
PME talks to Iskra Reic, the company’s head of Europe and Canada...
The era of digital wellbeing
Social media - friend or foe?...

Infographics